PDT Kills Drug-Resistant Bacteria, Fungus
Posted on: Saturday, 11 March 2006, 15:00 CST
Photodynamic therapy could treat fungal infections and bacterial infections of the mouth, University at Buffalo's School of Dental Medicine research shows.
Researchers found that the bacteria S. mutans, as well as fungal organisms of the genus Candida, cultured from HIV patients were highly susceptible to killing with minimal doses of PDT, both in laboratory dishes and on biofilms grown on denture material.
PDT may provide an adjunct to current antibiotic treatment or an alternative where antibiotics no longer are working, said Thomas S. Mang, Ph.D., associate professor of oral and maxillofacial surgery. This may be vital for patients undergoing cancer therapy, HIV patients who demonstrate resistance to antibiotics and the elderly with persistent oral infections.
Photodynamic therapy is based on the propensity of certain types of cells or organisms to absorb light-sensitive drugs. This selective retention allows researchers to direct a laser beam into the organism, activating the drug and killing the organism without damaging surrounding tissue.
Source: United Press International
Related Articles
- Patient Infection Rates Controlled by Unique Program at Outpatient Cancer Clinic
- ISENTRESS(TM) (Raltegravir), in Combination With Optimized Background Therapy (OBT), Provided Sustained Viral Suppression in Highly Treatment-Experienced Patients Infected With HIV, Through 48 Weeks
- European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected With CCR5-Tropic HIV-1
- Pfizer Receives Positive Opinion From CHMP for Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected With CCR5-Tropic HIV-1
- FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected With CCR5-Tropic HIV-1
- NxStage(R) Achieves Milestone With 1,000 Patients Receiving Therapy
- Human Genome Sciences Reports Positive Results of Phase 1 Clinical Trial of CCR5 mAb in Patients Infected With HIV-1
- Oklahoma Doctors Give Patients Information Therapy (Ix(R)) To Improve Care Quality
- Many Colon Cancer Patients Lack Therapy
- Hospital Patients Infected
 |
 |
User Comments (0)
RSS Feeds